Clinical Trial Update: Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial (ADIPOSA) evaluating the effect of a sodium-glucose cotransporter 2 (SGLT2) inhibitor on sleep apnea. The study is currently recruiting a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sleep Apnea

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: Yale University | Conditions: Sleep Apnea | Phase 4 | Status: RECRUITING